Regulation of the Gene for CD34, a Human Hematopoietic Stem Cell Antigen, in KG-1 Cells

CD34 is one of the best characterized human hematopoietic stem cell antigens defined to date. It is expressed on 1 % to 4% of normal bone marrow cells, including colony forming units of all lineages and their precursors. CD34 expression is lost during hematopoietic development and is not found on ma...

Full description

Saved in:
Bibliographic Details
Published in:Blood 1990-06, Vol.75 (12), p.2299-2304
Main Authors: Satterthwaite, Anne B., Borson, Rachel, Tenen, Daniel G.
Format: Article
Language:English
Subjects:
Antigens, CD - genetics
Antigens, CD - metabolism
Antigens, CD34
Antigens, Differentiation - genetics
Biological and medical sciences
Blotting, Northern
Cell Differentiation - drug effects
Cycloheximide - pharmacology
Fundamental and applied biological sciences. Psychology
Gene expression
Gene Expression Regulation - drug effects
Hematopoietic Stem Cells - physiology
Humans
Ionomycin - pharmacology
Macrophages - physiology
Molecular and cellular biology
Molecular genetics
RNA Processing, Post-Transcriptional - drug effects
RNA, Messenger - genetics
Tetradecanoylphorbol Acetate - pharmacology
Transcription, Genetic - drug effects
Tumor Cells, Cultured
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:CD34 is one of the best characterized human hematopoietic stem cell antigens defined to date. It is expressed on 1 % to 4% of normal bone marrow cells, including colony forming units of all lineages and their precursors. CD34 expression is lost during hematopoietic development and is not found on mature peripheral blood cells. The control of CD34 expression was studied in the myeloblast cell line KG-1 as a model for the regulation of stem cell genes. CD34 mRNA was expressed at high levels in uninduced KG-1 cells. Upon induction of the cells towards macrophages with tetradecanoylphorbol-13-acetate (TPA) and ionomy-cin, steady state levels of CD34 mRNA decreased rapidly. Nuclear run-on assays did not show a significant change in the rate of CD34 transcription upon induction. The half-life of CD34 mRNA was 4.5 hours in uninduced KG-1 cells and 2.25 hours in induced cells, demonstrating the involvement of post-transcriptional mechanisms in CD34 downregulation. Cycloheximide had no effect on the downregulation of CD34, suggesting that labile proteins are not required for this process. This model should allow the study of some of the regulatory mechanisms controlling early events in hematopoiesis.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V75.12.2299.2299